Early results of pre-exposure prophylaxis (PrEP) are promising, but gay men are not rushing to take the drug that could help them avoid HIV. Why not? In the final segment of Daily Xtra’s four-part video series, Nicolas Kazamia investigates why so few gay men are embracing the promise of PrEP. Check back with Daily Xtra for our ongoing coverage.

Early study results on the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV transmission are promising, but gay men are not rushing to take the drug. Why not?

In the fourth part of Daily Xtra’s four-part series, Nicolas Kazamia investigates why so few gay men are embracing the promise of PrEP. Interviewees include Robert Grant, a senior researcher at the Gladstone Institutes; HIV/AIDS prevention workers Tim Ryan and Steve Gibson, from Magnet, a sexual health clinic in San Francisco; and Alan McCord, from Project Inform.

Check back to Daily Xtra for our continuing coverage of PrEP. And follow the discussion on our Facebook page and on Twitter.

In the series:

Part 1: Can a pill a day keep HIV away?

Part 2: A condom-free future?

Part 3: The controversy behind PrEP

If gay men can avoid HIV with a pill, why aren’t they taking it?

Read More About:

Keep Reading

Advocates mount new challenge to Alberta anti-trans law

Dylan Mulvaney’s Broadway debut is about more than the backlash

Inside the censorship campaign against this 20th century lesbian novel

Publishers are acquiring fewer queer books due to U.S. book bans: Report